摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-propyl-2,4-bis(trimethylsilyloxy)pyrimidine | 917567-69-2

中文名称
——
中文别名
——
英文名称
6-propyl-2,4-bis(trimethylsilyloxy)pyrimidine
英文别名
4-Propyl-2,6-bis[(trimethylsilyl)oxy]pyrimidine;trimethyl-(4-propyl-6-trimethylsilyloxypyrimidin-2-yl)oxysilane
6-propyl-2,4-bis(trimethylsilyloxy)pyrimidine化学式
CAS
917567-69-2
化学式
C13H26N2O2Si2
mdl
——
分子量
298.533
InChiKey
VHJSYODVRXJYRM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    320.3±44.0 °C(Predicted)
  • 密度:
    0.960±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.86
  • 重原子数:
    19
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.69
  • 拓扑面积:
    44.2
  • 氢给体数:
    0
  • 氢受体数:
    4

SDS

SDS:6160fe09edbc7a87adbd9e585fe215e0
查看

反应信息

  • 作为反应物:
    描述:
    6-propyl-2,4-bis(trimethylsilyloxy)pyrimidinesodium methylate四氯化锡 作用下, 以 甲醇1,2-二氯乙烷 为溶剂, 反应 8.0h, 生成 6-propyl-3-β-D-ribofuranosyl(1H)pyrimidine-2,4-dione
    参考文献:
    名称:
    Synthesis and Structure−Activity Relationships of Uracil Nucleotide Derivatives and Analogues as Agonists at Human P2Y2, P2Y4, and P2Y6 Receptors
    摘要:
    A series of UTP, UDP, and UMP derivatives and analogues were synthesized and evaluated at the human pyrimidinergic P2Y receptor subtypes P2Y(2), P2Y(4), and P2Y(6) stably expressed in 1321N1 astrocytoma cells. Substituents at N3 of UTP were poorly tolerated by P2Y2 and P2Y4 receptors. In contrast, a large phenacyl substituent at N3 of UDP was well tolerated by the P2Y6 receptor, yielding a potent and selective P2Y6 receptor agonist (3-phenacyl-UDP, EC50 = 70 nM, > 500-fold selective). The most potent and selective P2Y2 receptor agonist of the present series was 2-thio-UTP (EC50 = 50 nM, >= 30-fold selective vs P2Y(4) and P2Y6). All modifications at the uracil base of UTP led to a decrease in potency at the P2Y4 receptor. A beta,gamma-dichloromethylene modification in the triphosphate chain of 5-bromo-UTP was tolerated by all three receptor subtypes, thus opening up a new strategy to obtain ectonucleotide diphosphohydrolase- and phosphatase-resistant P2Y(2), P2Y(4), and P2Y(6) receptor agonists.
    DOI:
    10.1021/jm060848j
  • 作为产物:
    描述:
    丙硫氧嘧啶三甲基氯硅烷氯乙酸 作用下, 以 为溶剂, 反应 5.0h, 生成 6-propyl-2,4-bis(trimethylsilyloxy)pyrimidine
    参考文献:
    名称:
    Synthesis and Structure−Activity Relationships of Uracil Nucleotide Derivatives and Analogues as Agonists at Human P2Y2, P2Y4, and P2Y6 Receptors
    摘要:
    A series of UTP, UDP, and UMP derivatives and analogues were synthesized and evaluated at the human pyrimidinergic P2Y receptor subtypes P2Y(2), P2Y(4), and P2Y(6) stably expressed in 1321N1 astrocytoma cells. Substituents at N3 of UTP were poorly tolerated by P2Y2 and P2Y4 receptors. In contrast, a large phenacyl substituent at N3 of UDP was well tolerated by the P2Y6 receptor, yielding a potent and selective P2Y6 receptor agonist (3-phenacyl-UDP, EC50 = 70 nM, > 500-fold selective). The most potent and selective P2Y2 receptor agonist of the present series was 2-thio-UTP (EC50 = 50 nM, >= 30-fold selective vs P2Y(4) and P2Y6). All modifications at the uracil base of UTP led to a decrease in potency at the P2Y4 receptor. A beta,gamma-dichloromethylene modification in the triphosphate chain of 5-bromo-UTP was tolerated by all three receptor subtypes, thus opening up a new strategy to obtain ectonucleotide diphosphohydrolase- and phosphatase-resistant P2Y(2), P2Y(4), and P2Y(6) receptor agonists.
    DOI:
    10.1021/jm060848j
点击查看最新优质反应信息

文献信息

  • Synthesis of an AZT-HEPT Hybrid and Homologous AzddU Derivatives.
    作者:Erik Larsen、Krzysztof Danel、Gitte B. Vaaben、Ali A. El-Emam、Erik B. Pedersen、Claus Nielsen、Shu Hai Zhao、Mauro I. Ciglic、Monika Haugg、Nathalie Trabesinger-Rüf、Elmar G. Weinhold
    DOI:10.3891/acta.chem.scand.50-0417
    日期:——
    3'-Azido-2',3'-dideoxyuridines 6 and their corresponding cc anomers 5 were synthesized by condensation of silylated 6-alkyl and 5,6-dialkyl substituted uracils 2 with methyl 3-azido-5-O-tert-butyldiphenylsilyl-2,3-dideoxy-alpha-beta-D-erythro-pentofuranoside (4). Compounds 5 and 6 were treated with tetrabutylammonium fluoride to obtain the deprotected nucleosides 7 and 8, respectively.
  • Synthesis and Structure−Activity Relationships of Uracil Nucleotide Derivatives and Analogues as Agonists at Human P2Y<sub>2</sub>, P2Y<sub>4</sub>, and P2Y<sub>6</sub> Receptors
    作者:Ali El-Tayeb、Aidong Qi、Christa E. Müller
    DOI:10.1021/jm060848j
    日期:2006.11.30
    A series of UTP, UDP, and UMP derivatives and analogues were synthesized and evaluated at the human pyrimidinergic P2Y receptor subtypes P2Y(2), P2Y(4), and P2Y(6) stably expressed in 1321N1 astrocytoma cells. Substituents at N3 of UTP were poorly tolerated by P2Y2 and P2Y4 receptors. In contrast, a large phenacyl substituent at N3 of UDP was well tolerated by the P2Y6 receptor, yielding a potent and selective P2Y6 receptor agonist (3-phenacyl-UDP, EC50 = 70 nM, > 500-fold selective). The most potent and selective P2Y2 receptor agonist of the present series was 2-thio-UTP (EC50 = 50 nM, >= 30-fold selective vs P2Y(4) and P2Y6). All modifications at the uracil base of UTP led to a decrease in potency at the P2Y4 receptor. A beta,gamma-dichloromethylene modification in the triphosphate chain of 5-bromo-UTP was tolerated by all three receptor subtypes, thus opening up a new strategy to obtain ectonucleotide diphosphohydrolase- and phosphatase-resistant P2Y(2), P2Y(4), and P2Y(6) receptor agonists.
查看更多